Related Experiment Video
Updated: Feb 8, 2026

Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
Published on: September 3, 2016
miR-129-5p suppresses breast cancer proliferation by targeting CBX4
R Meng1,2,3, J Fang1,2,3,4, Y Yu1,2,3
1The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China
Abstract:
Deregulation of microRNA (miRNA) is closely related to cancer development and progression. Our previous study identified that miR-129-5p suppresses proliferation and metastasis in breast cancer cells. Herein, we determined that CBX4 is a miR-129-5p target gene. CBX4 is up-regulated in breast cancer tissues and while its over-expression promotes cell proliferation, its knockdown suppresses cell proliferation in breast cancer cells. Furthermore, CBX4 mediates miR-129-5p-induced inhibition of cell proliferation and negatively correlates with the expression of miR-129-5p expression. These combined results suggest that CBX4 is an oncogene in breast cancer cells, and that it may provide a novel therapeutic strategy for breast cancer treatment.
Insights
MicroRNA-129-5p targets CBX4, an oncogene in breast cancer. CBX4 promotes cancer cell growth, and its inhibition by miR-129-5p offers a potential therapeutic strategy for breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA (miRNA) deregulation is implicated in cancer development.
- Previous research indicated miR-129-5p inhibits breast cancer cell proliferation and metastasis.
Purpose of the Study:
- To identify miR-129-5p target genes.
- To investigate the role of CBX4 in breast cancer progression.
- To explore the therapeutic potential of the miR-129-5p/CBX4 axis.
Main Methods:
- Bioinformatic analysis to predict miR-129-5p targets.
- Western blotting and qRT-PCR to assess gene and protein expression.
- Cell proliferation assays (e.g., MTT, colony formation).
- CBX4 knockdown and overexpression experiments in breast cancer cell lines.
Main Results:
- CBX4 was identified as a direct target gene of miR-129-5p.
- CBX4 expression is upregulated in breast cancer tissues.
- CBX4 overexpression enhances breast cancer cell proliferation, while its knockdown inhibits it.
- CBX4 mediates the anti-proliferative effects of miR-129-5p.
- CBX4 expression negatively correlates with miR-129-5p levels in breast cancer.
Conclusions:
- CBX4 functions as an oncogene in breast cancer.
- The miR-129-5p/CBX4 pathway plays a critical role in breast cancer progression.
- Targeting CBX4 represents a potential novel therapeutic strategy for breast cancer treatment.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation
Cells Coordinate Growth and Proliferation
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Cancer

